Necmettin Erbakan University Meram Medical Faculty ; Internal Diseases
About Necmettin Erbakan University Meram Medical Faculty ; Internal Diseases
Necmettin Erbakan University is a public university in Konya, Turkey.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Dokuz Eylul University
2
Eli Lilly and Company
2
Clinical Trials at Necmettin Erbakan University Meram Medical Faculty ; Internal Diseases
During the past decade, Necmettin Erbakan University Meram Medical Faculty ; Internal Diseases conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on
average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab With Chemoradiotherapy in the Adjuvant Setting in Operated Participants With Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Gastric or Gastroesophageal Junction Cancer
2013-01-29
2017-06-15
Completed
34
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer
2013-06-10
2019-12-31
Completed
780
A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer
2018-01-11
2024-01-31
Recruiting
572
A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
2021-10-22
2028-06-14
Recruiting
90
A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer
2021-11-18
2026-03-06
Recruiting
690
A Study of LY3561774 in Participants With Mixed Dyslipidemia
2022-07-20
2024-04-25
Recruiting
175
The Effect of Mobile Application Robot Developed for Pediatric Diabetes Management on Children With Diabetes Mellitus (DM)
2023-05-01
2024-07-01
Not yet recruiting
34
The Effect of Mobile Application Robot Developed for Pediatric Diabetes Management on Children With Diabetes Mellitus
2023-05-01
2024-07-01
Not yet recruiting
34
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Necmettin Erbakan University Meram Medical Faculty ; Internal Diseases"
#1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator, "Jazz Pharmaceuticals" with 1 trials as a collaborator and "Necmettin Erbakan University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Necmettin Erbakan University Meram Medical Faculty ; Internal Diseases
According to Clinical.Site data, the most researched conditions in "Necmettin Erbakan University Meram Medical Faculty ; Internal Diseases" are
"Adolescent" (2 trials), "Diabetes Mellitus, Type 1" (2 trials), "Gastric Cancer" (2 trials), "Atypical Hemolytic Uremic Syndrome" (1 trials) and "Child" (1 trials). Many other conditions were trialed in "Necmettin Erbakan University Meram Medical Faculty ; Internal Diseases" in a lesser frequency.
Clinical Trials Intervention Types at Necmettin Erbakan University Meram Medical Faculty ; Internal Diseases
Most popular intervention types in "Necmettin Erbakan University Meram Medical Faculty ; Internal Diseases" are "Drug" (7 trials), "Behavioral" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Capecitabine" (3 trials), "Atezolizumab" (2 trials), "Carboplatin" (2 trials) and "DİABOT (mobile application robot )" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Necmettin Erbakan University Meram Medical Faculty ; Internal Diseases
The vast majority of trials in "Necmettin Erbakan University Meram Medical Faculty ; Internal Diseases" are
9 trials for "All" genders.
Clinical Trials Status at Necmettin Erbakan University Meram Medical Faculty ; Internal Diseases
Currently, there are NaN active trials in "Necmettin Erbakan University Meram Medical Faculty ; Internal Diseases".
2 are not yet recruiting,
5 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Necmettin Erbakan University Meram Medical Faculty ; Internal Diseases,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Necmettin Erbakan University Meram Medical Faculty ; Internal Diseases, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".